146 related articles for article (PubMed ID: 8638301)
1. [Results of radiotherapy of ureteral obstruction in invasive bladder cancer].
Holm M; Miskowiak J; Rolff H
Ugeskr Laeger; 1996 Jan; 158(4):420-1. PubMed ID: 8638301
[TBL] [Abstract][Full Text] [Related]
2. Results of radiotherapy on ureteric obstruction in muscle-invasive bladder cancer.
Honnens de Lichtenberg M; Miskowiak J; Rolff H
Br J Urol; 1995 Feb; 75(2):197-9. PubMed ID: 7850326
[TBL] [Abstract][Full Text] [Related]
3. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
4. [Endo-urological drainage in urinary outflow obstruction caused by cancer].
Stevens A; van Driel MF; Klein JP; de Ruiter AJ; Mensink HJ
Ned Tijdschr Geneeskd; 1994 Mar; 138(10):522-5. PubMed ID: 8139712
[TBL] [Abstract][Full Text] [Related]
5. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
6. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
[TBL] [Abstract][Full Text] [Related]
8. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
[TBL] [Abstract][Full Text] [Related]
9. [Endoscopic management of bilateral ureteral obstruction after radiotherapy].
Zeng GH; Li X; Wu KJ; Chen WZ
Ai Zheng; 2004 Jan; 23(1):108-9. PubMed ID: 14720387
[TBL] [Abstract][Full Text] [Related]
10. Management of benign ureteral strictures following radical cystectomy and urinary diversion for bladder cancer.
Tal R; Sivan B; Kedar D; Baniel J
J Urol; 2007 Aug; 178(2):538-42. PubMed ID: 17570422
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in malignant ureteric obstruction.
Lienert A; Ing A; Mark S
BJU Int; 2009 Oct; 104(7):938-41. PubMed ID: 19338533
[TBL] [Abstract][Full Text] [Related]
12. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
[TBL] [Abstract][Full Text] [Related]
13. APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer.
Sak SC; Harnden P; Johnston CF; Paul AB; Kiltie AE
Clin Cancer Res; 2005 Sep; 11(17):6205-11. PubMed ID: 16144922
[TBL] [Abstract][Full Text] [Related]
14. Malignant ureteral obstruction: outcomes after intervention. Have things changed?
Wong LM; Cleeve LK; Milner AD; Pitman AG
J Urol; 2007 Jul; 178(1):178-83; discussion 183. PubMed ID: 17499300
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer.
Fokdal L; Høyer M; von der Maase H
Acta Oncol; 2004; 43(8):749-57. PubMed ID: 15764221
[TBL] [Abstract][Full Text] [Related]
16. The outcome with ureteric stents for managing non-urological malignant ureteric obstruction.
Jeong IG; Han KS; Joung JY; Seo HK; Chung J
BJU Int; 2007 Dec; 100(6):1288-91. PubMed ID: 17850371
[TBL] [Abstract][Full Text] [Related]
17. Organ-sparing treatment in muscle-invasive bladder cancer.
Dunst J; Diestelhorst A; Kühn R; Müller AC; Scholz HJ; Fornara P
Strahlenther Onkol; 2005 Oct; 181(10):632-7. PubMed ID: 16220401
[TBL] [Abstract][Full Text] [Related]
18. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.
Kotwal S; Choudhury A; Johnston C; Paul AB; Whelan P; Kiltie AE
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):456-63. PubMed ID: 17904301
[TBL] [Abstract][Full Text] [Related]
19. [Percutaneous nephrostomy in malignant ureteral obstruction].
Demetriou D; Sebeikat D
Dtsch Med Wochenschr; 1996 Dec; 121(49):1526-30. PubMed ID: 8998920
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
